531 - 540 of 8399 Results
Title
Year
-
OPENTitle: Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 11Start Page: 1717End Page: 1731Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-024-01338-yBest OA location URL: https://www.nature.com/articles/s41594-024-01338-y.pdfCitation Count: 11
-
OPENTitle: Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00741-yCitation Count: 3
-
OPENTitle: Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman PrimatesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 11Issue #: 7Start Page: ENEURO.0001End Page: 24.2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0001-24.2024Best OA location URL: https://www.eneuro.org/content/eneuro/early/2024/06/25/ENEURO.0001-24.2024.full.pdfCitation Count: 3
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease2024OPENTitle: The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65640-xBest OA location URL: https://www.nature.com/articles/s41598-024-65640-x.pdfCitation Count: 4
-
OPENTitle: An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain agingJournal Name: Aging CellPublisher: WileyVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.14230Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.14230Citation Count: 3
-
OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page: 1103End Page: 1112Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14145Citation Count: 6
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03702-3Citation Count: 4
- Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants2024RESTRICTEDTitle: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107041End Page: 107041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041Citation Count: 0
-
OPENTitle: Open-source platform for kinematic analysis of mouse forelimb movementJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 5Issue #: 3Start Page: 103140End Page: 103140Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xpro.2024.103140Citation Count: 0
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Citation Count: 8